The Controversial Pricing of Moderna's COVID Vaccine Defended by CEO in Senate Hearing.
TL;DR Summary
Moderna, the pharmaceutical company that developed one of the COVID-19 vaccines, plans to increase the price of its vaccine to between $32 and $37 per dose for most customers, and up to $130 per dose for some customers. The company says the price hike is due to the need to invest in research and development for future vaccines, but some experts are concerned about the affordability of the vaccine for lower-income countries.
- Moderna plans to hike COVID vaccine to as high as $130 KOMO News
- Bernie Sanders puts forth an accidentally great drug pricing idea STAT
- Sen. Sanders shows fire, but seeks modest goals, in his debut drug hearing as health chair Salon
- Opinion | 'A 400% Price Increase Is Preposterous': What We Heard This Week Medpage Today
- Moderna CEO defends US$130 COVID-19 vaccine price in U.S. Senate hearing CTV News
Reading Insights
Total Reads
0
Unique Readers
19
Time Saved
0 min
vs 1 min read
Condensed
-700%
9 → 72 words
Want the full story? Read the original article
Read on KOMO News